Morgan Stanley Organogenesis Holdings Inc. Transaction History
Morgan Stanley
- $1.23 Trillion
- Q1 2024
A detailed history of Morgan Stanley transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Morgan Stanley holds 11,528,028 shares of ORGO stock, worth $32.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,528,028
Previous 13,377,756
13.83%
Holding current value
$32.3 Million
Previous $54.7 Million
40.16%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ORGO
# of Institutions
129Shares Held
56.3MCall Options Held
55.3KPut Options Held
22.2K-
Soleus Capital Management, L.P. Greenwich, CT9.57MShares$26.8 Million2.22% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$13.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.54MShares$9.9 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3MShares$8.4 Million0.03% of portfolio
-
Deutsche Bank Ag\ Frankfurt Am Main, 2M2.51MShares$7.03 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $366M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...